1. Home
  2. PLXS vs RGEN Comparison

PLXS vs RGEN Comparison

Compare PLXS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PLXS

Plexus Corp.

HOLD

Current Price

$285.36

Market Cap

7.0B

Sector

Technology

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$145.13

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLXS
RGEN
Founded
1979
1981
Country
United States
United States
Employees
20000
N/A
Industry
Electrical Products
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
6.6B
IPO Year
1995
1995

Fundamental Metrics

Financial Performance
Metric
PLXS
RGEN
Price
$285.36
$145.13
Analyst Decision
Strong Buy
Buy
Analyst Count
4
12
Target Price
$206.50
$167.67
AVG Volume (30 Days)
274.0K
971.4K
Earning Date
04-29-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
56.11
286.96
EPS
3.32
0.15
Revenue
N/A
$141,236,000.00
Revenue This Year
$14.31
$14.30
Revenue Next Year
$8.29
$14.52
P/E Ratio
$89.39
$968.40
Revenue Growth
N/A
35.10
52 Week Low
$115.83
$100.99
52 Week High
$307.06
$175.77

Technical Indicators

Market Signals
Indicator
PLXS
RGEN
Relative Strength Index (RSI) 52.48 70.07
Support Level $269.81 $141.44
Resistance Level $292.33 $172.45
Average True Range (ATR) 11.23 6.22
MACD -1.35 1.41
Stochastic Oscillator 41.18 85.92

Price Performance

Historical Comparison
PLXS
RGEN

About PLXS Plexus Corp.

Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: